• On page 2, Materials and Methods, right column, first full paragraph, second sentence, "serum creatinine [mt] 2.8 mg/dL" has been corrected to "serum creatinine >2.8 mg/dL". The same correction was done in the sixth full paragraph, first sentence.
• On page 4, Results, right column, first full paragraph "Knox"
has been corrected to "NOx". The same correction was done on page 5, left column, first full paragraph, first and second sentences; page 5, right column, first full paragraph, first, second, and third sentences; page 5, right column, In Vitro Study, second full paragraph, first sentence; page 5, right column, In Vitro Study, third full paragraph, second sentence; page 6, Figure 2 legend, first sentence; page 7, right column, first full paragraph, second sentence; and page 8, Figure 4 legend, first and third sentences.
• On page 5, right column, first full paragraph "*P [lt] 0.001" has been corrected to "P<0.001". The same correction was done on page 8, Figure 4 legend, last sentence.
• On page 6, Figure 2 legend, last sentence, "P[lt]0.05" was corrected to "P<0.05". The same correction was carried out on page 9, Figure 3 legend, last sentence.
The publisher regret these errors.
The following errors were also corrected:
• On page 4, Results, right column, first full paragraph was updated, to correct the latter 3 figure citations, to read, "A significant difference for treatments (dark versus milk chocolate) was found with respect to FMD (P=0003; Figure 2A ), sNOX2-dp release (P=0.04; Figure 2B ), NOx (P=0.03; Figure 2C ), serum 8-iso-prostaglandin F2a-III (P=0.018; Figure 2D ), MWD (P=0.01; Figure 3A ), Maximal Walking Time (MWT) (P=0.006; Figure 3B ), and postexercise ABI (P=0.04; Figure 3D ) from the ANOVA performed on crossover study data."
